KOL Perspectives: Risankizumab in Crohn’s disease
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
› The briefing includes analysis of KOL opinion on the following topic areas:
– Risankizumab long-term efficacy
– Expected place of risankizumab in Crohn’s disease treatment algorithm
– Impact of single vs. multiple IV on convenience
– Future active comparators for trials
– Future Crohn’s disease patient subpopulations for trials
Scope
› The insight briefing is based on Sociable Pharma’s analysis of primary research with our inflammatory bowel disease key opinion leaders (KOLs)
› In total, we conducted interviews with 10 KOLs:
– 5 Europe-based & 5 N. America-based
– Interviews performed during June 2017
> KOL data is analyzed to produce:
– Charts summarizing KOL opinions
– Chart call-outs of key information & details
– KOL quotes
– Summary of KOL reporting trends
– Insight from Sociable Pharma's analysts
Key Highlights
Week 52 Phase II data for risankizumab appears to confirm KOL perceptions of its efficacy based on previous induction data
Strong Phase II data for risankizumab has led to some KOLs expecting it to replace UST as a first-line non-TNF therapy in Crohn’s disease
Most KOLs reported that risankizumab should be used as a monotherapy in most patients unless further studies highlight a significant issue with immunogenicity or reduced efficacy when used alone
Reasons to Buy
Combines Qualitative & semi-quantitative insight from key opinion leaders on " Risankizumab in Crohn’s disease "
Includes insight & recommendations from our disease-specific healthcare analysts
Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of Crohn's disease
Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion
Takeda
Janssen
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.